Comparison of goserelin and leuprolide in combined androgen blockade therapy
- 1 July 1998
- Vol. 52 (1) , 82-88
- https://doi.org/10.1016/s0090-4295(98)00145-9
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Prostate Specific Antigen Decreases After Withdrawal of Antiandrogen Therapy with Bicalutamide or Flutamide in Patients Receiving Combined Androgen BlockadeJournal of Urology, 1997
- Advanced prostate cancerPostgraduate Medicine, 1996
- Maximal androgen blockade for patients with metastatic prostate cancer: outcome of a controlled trial of bicalutamide versus flutamide, each in combination with luteinizing hormone-releasing hormone analogue therapyUrology, 1996
- Goserelin versus orchiectomy in the treatment of advanced prostate cancer: Final results of a randomized trialUrology, 1995
- A controlled trial of bicalutamide versus flutamide, each in combination with luteinizing hormone-releasing hormone analogue therapy, in patients with advanced prostate cancerUrology, 1995
- Goserelin acetate and flutamide versus bilateral orchiectomy: a phase III eortc trial (30853)Urology, 1993
- Comparison of LHRH Analogue (Zoladex) with Orchiectomy in Patients with Metastatic Prostatic CarcinomaBritish Journal of Urology, 1991
- A Controlled Trial of Leuprolide with and without Flutamide in Prostatic CarcinomaNew England Journal of Medicine, 1989
- Patients' choice of treatment in stage D prostate cancerPublished by Elsevier ,1989
- Leuprolide versus Diethylstilbestrol for Metastatic Prostate CancerNew England Journal of Medicine, 1984